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REGULATION OF THE NA +fH+ ANTIPORT IN Xenopus laevis 
OOCYTES DURING MEIOTIC MATURATION 
Xenopus laevis oocytes undergo an increase in their intracellular pH in reponse to 
progesterone stimulation. This increase in pHi is due to the activation of a Na+fH+ antiport 
in the plasma membrane of the oocyte. In other cell systems, it appears that 
phosphorylation of the Na+fH+ exchanger induces its activation. The goal of my study 
was to identify the kinase(s) involved in regulation of the antiporter during oocyte 
maturation. I have demonstrated that protein kinase C, calmodulin kinase, and p34 MPF 
kinase are not involved in regulating the Na+fH+ antiporter during progesterone-induced 
oocyte meiotic maturation. Protein kinase A appears to be antagonistic to the activation of 
this exchanger. 
Protein synthesis appears to be required for steroidal activation of the antiporter, most 
likely the synthesis of c-mos. Microinjected p39 c-mos kinase can rapidly activate the 
Na+fH+ antiporter in full-grown stage VI and in smaller stage IV recipient oocytes. It 
appears that p39 c-mos kinase or another kinase immediately downstream of c-mos is is 
involved in regulation of the Na+fH+ antiporter. 
Copyright by Katayoun Rezai, 1994 
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The Na+JH+ exchanger was first studied in renal systems, and it was proposed that this 
exchanger is involved in renal acidification and in transepithelial salt and water transport. 
However, recent studies have shown that the Na+JH+ exchanger is not unique to epithelial 
tissues (Grinstein and Rothstein, 1986). The Na+JH+ antiporter is a plasma membrane 
transporter that appears to be present in almost all cells, and it is thought to be involved in a 
variety of cellular functions including regulation of intracellular pH, control of cell volume, 
and initiation of growth and proliferation (Sardet et al., 1990). 
With regards to the regulation of intracellular pH, this antiporter exchanges one Na+ 
ion into the cell for each H+ ion released. In fertilized sea urchin eggs, a correlation 
between intracellular alkalinization and an increase in the rate of protein synthesis has been 
demonstrated (Grainger et al., 1979). Furthermore, in Xenopus laevis oocytes, it has been 
suggested that an increase in intracellular pH plays an important role in regulating the 
synthesis of proteins needed for maturation of the oocyte (Houle and Wasserman, 1983). 
Due to the importance of intracellular pH changes during meiotic maturation, the purpose 
of my study was to examine the regulation of the Na+/H+ antiporter in Xenopus laevis 
oocytes. 
My working hypothesis is that the rise in intracellular pH (pHi) during oocyte 
maturation is due to the stimulation of the Na+JH+ antiporter via phosphorylation. This 
phosphorylation is regulated by one or more protein kinases. In this study the potential 
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role of three different kinases was investigated: protein kinase C, calcium-calmodulin 
kinase, and cAMP-dependent protein kinase. The goal of my study was to determine if 
progesterone regulates the Na+ /H+ antiporter via phosphorylation during oocyte 
maturation. To achieve this goal I employed the following strategies: 
1) Confirm that the progesterone-induced pHi rise during oocyte maturation is due to 
stimulation of the Na+fH+ antiporter. 
2) Attempt to stimulate the Na+/H+ antiporter artificially using activators of protein 
kinase C, calcium-calmodulin kinase, or protein kinase A. 
3) Attempt to inhibit progesterone stimulation of the Na+fH+ antiporter by inhibiting 
these protein kinases. 
4) Propose one or more kinases that could be involved in the regulation of the Na+fH+ 
antiporter during progesterone-induced oocyte maturation. 
B. Literature Review: 
Meiotic cell division leads the egg to maturation and to generation of the haploid 
chromosome content necessary for continuation of the species after fertilization. Oocyte 
maturation has been studied in different vertebrate and invertebrate organisms, but research 
has been done extensively in amphibians (Smith, 1989). 
In Xenopus laevis , oocytes of different sizes are present in the ovary at the same time; 
that is, oogenesis is asynchronous. The growth period of these oocytes has been divided 
into six stages, I-VI, by Dumont (1972). Stage VI oocytes, which are the full-grown 
oocytes (1200-1300µm in diameter), are arrested in late G2 phase of meiosis I, and they 
have to progress to the second meiotic metaphase before fertilization can occur (reviewed 
by Smith, 1989). Full-grown oocytes are the only oocytes within the ovary that can 
resume meiosis from prophase arrest (Wasserman et al., 1986). 
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The resumption of meiosis is normally triggered by an external stimulus which most 
often is a hormone (Wasserman et al., 1986). In vivo, meiotic maturation is triggered by 
luteinizing hormone (LH), released from the anterior pituitary. LH is carried via the 
circulatory system to the ovary where it stimulates the follicle cells surrounding the oocytes 
to synthesize and release the steroid progesterone. Progesterone is the trigger for meiotic 
resumption (Masui and Markert, 1971). Progesterone does not interact with oocytes in the 
same way that it does with other target cells. Steroids are usually translocated to the 
nucleus where they alter specific gene transcription (Beato, 1989). Rather, in the oocyte 
progesterone acts as a signal at or near the plasma membrane of the cell. The signal is 
transduced across the plama membrane into the cytoplasm, triggering a complex chain of 
reactions called "meiotic maturation." It has been shown by different studies that 
progesterone must act at or near the plasma membrane of the oocyte. Progesterone can not 
induce maturation from within the oocyte. Microinjecting progesterone into stage VI 
oocytes will not induce maturation in Rana pipiens or Xenopus oocytes (Masui and 
Markert, 1971; Wasserman et al., 1986). However, if progesterone is bound covalently to 
polystyrene beads and does not enter the oocyte, it is still able to induce maturation 
(Godeau et al., 1978). Preliminary studies have allowed researchers to identify a steroid 
receptor on the surface of Xenopus oocytes by photoaffinity labeling (Sadler and Maller, 
1982; Blondeau and Baulieu, 1984). 
Progesterone-induced maturation at the morphological level involves migration of the 
oocyte nucleus (germinal vesicle, GV) to the animal pole, dissolution of the nuclear 
envelope (germinal vesicle breakdown, GVBD), chromosome condensation, spindle 
formation, and segregation of homologous chromosomes. The migration of the germinal 
vesicle toward the animal pole causes the displacement of pigment granules, resulting in a 
white circular spot surrounded by a dark band (displaced pigment). The white spot is the 
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first visible indication of oocyte maturation, and its appearance is the easiest way to score 
for maturation or GVBD. However, to ensure that GVBD has occurred, oocytes are fixed 
in Trichloroacetic acid (TCA) and broken open to look for the presence or absence of the 
GV (reviewed by Smith, 1989). 
Many physiological events are also occurring at the same time. Some of the early 
events include a transient increase in intracellular Ca2+ and a drop in cAMP levels. Other 
events are an increase in intracellular pH (0.3-0.4 units), an increase in protein synthesis, 
an increase in total protein phosphorylation, and the appearance of a cytoplasmic factor, 
maturation promoting factor (MPF), which is responsible for GVBD and chromosome 
condensation (Wasserman and Smith, 1978). 
The sum of these morphological and physiological events constitute oocyte maturation. 
The mechanism by which progesterone triggers these events has been compared to the 
transmembrane signalling events for peptide hormones. One hypothesis is that 
progesterone indirectly regulates the intracellular events by activating OTP-binding 
G-proteins leading to changes in the intracellular concentrations of second messengers. 
Phospholipase C activation would result in hydrolysis of membrane-bound 
phosphotidylinositol, 4,5-bisphosphate (PIP2), which generates inositol triphosphate 
(IP 3) and 1,2-diacylglycerol (DAG), two of the second messengers. IP 3 causes the release 
of Ca2+ from the endoplasmic reticulum. The increase in ea2+ concentration could activate 
calmodulin-dependent kinase (CaM). Furthermore, DAG could activate protein kinase C 
(PKC). Another second messenger is cAMP, which decreases during oocyte maturation. 
cAMP regulates another kinase known as protein kinase A (PKA) or cyclic AMP-
dependent kinase (reviewed by Eckberg, 1988). 
The regulation of some of the physiological and morphological events during 
maturation has been studied. One of these events is an intracellular pH increase of 0.3-0.4 
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units. Studies have shown that the increase in intracellular pH may play a direct or indirect 
role in regulation of the observed increase in the rate of protein synthesis. A full-grown 
stage VI Xenopus laevis oocyte has a pHi of 7.2-7.3 and a rate of protein synthesis of 
about 20ng/hr. However, a mature oocyte has a pHi of 7.6-7.7 and a rate of protein 
synthesis of about 40ng/hr. It has been shown that artificial alkalinization of an oocyte can 
cause a comparable increase in the rate of protein synthesis (Houle and Wasserman, 1983). 
These data suggest that pHi may play an important role in regulating the synthesis of 
proteins needed for maturation of the oocyte. 
Regulation of intracellular pH has been studied mainly in cultured cells in which 
control of pHi is important for the cell's metabolic activity, or in sea-urchin eggs during 
fertilization. However, there is a similarity in most cell systems studied in that the increase 
in pHi appears to be due to stimulation of the Na+JH+ antiporter. In Xenopus laevis 
oocytes, replacement of extracellular sodium with choline chloride, or treatment with the 
Na+/H+ antiporter inhibitor amiloride, prevents the pHi rise in response to progesterone 
(Wasserman and Houle, 1984; Stith and Maller, 1985). In a recent study, the uptake of 
22Na+ and release of H+ were shown to be inhibited by amiloride in Xenopus oocytes 
(Towle et al., 1991). 
Since the pHi rise is due to the Na+/H+ antiporter, my research interest has been 
directed toward determining how the Na+fH+ antiporter is regulated. The basic hypothesis 
is that phosphorylation of the Na+fH+ antiporter stimulates H+ efflux and Na+ influx and 
causes the pHi to increase. It is proposed that phosphorylation induces a conformational 
change in the Na+fH+ antiporter, resulting in an increase in the affinity of the antiporter for 
H+ (Wakabayashi, et al., 1992). In regards to phosphorylation of the exchanger, there 
have been studies showing that stimulated Na+fH+ exchange activity is correlated with an 
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increase in the phosphorylation of a transmembrane glycoprotein of 110 kDa known as 
NHEl in cells such as fibroblasts, epithelial cells, and blood platelets (Livne et al., 1991; 
Sardet et al., 1989, 1990; Wakabayashi et al., 1992). Furthermore, cells that lack a 
Na+/H+ antiporter gain this exchanger activity when transfected with a cDNA for NHEl 
(Sardet et al., 1990). This is the only direct evidence that phosphorylation of the Na+fH+ 
antiporter may play a regulatory role. An alternative hypothesis is that the exchanger is 
regulated via a non-phosphorylation mechanism. However, there has not been any 
evidence showing a non-phosphorylation mechanism for regulating the Na+/H+ antiporter. 
Most studies have used inhibitors to determine which kinase(s) may be involved in this 
phosphorylation event. This is an indirect way of determining how the exchanger is 
regulated. One of the potential kinases that has been studied is protein kinase C (PKC). 
As described before, DAG appears to be the normal intracellular activator of PKC. 
Wasserman et al. (1990) showed that oocyte DAG levels increase significantly shortly 
after progesterone is added, and also that the addition of DAG could cause a small increase 
in the intracellular pH of Xenopus laevis oocytes in the absence of progesterone 
stimulation. Furthermore, Stith and Maller (1987) examined the effect of a tumor 
promoter, 12-0-tetra decanoyl phorbol 13-acetate (TPA, phorbol ester), a very potent 
activator of PKC, on Xenopus laevis oocytes. They found that the intracellular pH in 
Xenopus oocytes increased slightly in response to the phorbol ester. However, in their 
study there was no direct evidence that TPA was stimulating the Na+/H+ antiporter. Based 
on these preliminary studies, there is the possibility that PKC could be involved in the 
regulation of the Na+ fH+ antiporter in Xenopus oocytes. 
The regulation of the Na+/H+ antiporter via PKC has also been examined in fertilized 
sea urchin eggs. During fertilization the Na+/H+ antiporter activity increases, causing a 
cytoplasmic alkalinization (Shen and Buck, 1990). This alkalinization has been correlated 
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with an increase in the rate of protein synthesis following fertilization (Grainger et al., 
1979). Shen and Buck (1990) observed that the rise in pHi during fertilization of sea 
urchin eggs could be partially blocked by a very specific inhibitor of PKC, a 
pseudosubstrate of PKC known as PKC(19-36). These results suggested that PKC could 
be involved in the regulation of the Na+JH+ antiporter during sea-urchin egg fertilization. 
The vascular smooth muscle cell in rat is another cell system in which pH regulation 
has been studied. Regulation of intracellular pH is important in the contractile tone and 
growth of the vascular smooth muscle cells. In these cells, pHi is more alkaline in 
proliferating cells than in growth-arrested cells. TPA induces a pHi rise in the 
growth-arrested cells. Furthermore, sphingosine, a potent PKC inhibitor, blocks the effect 
of TP A. Mitsuka and Berk ( 1991) concluded that PKC is involved in the regulation of the 
Na+JH+ antiporter in vascular smooth muscle cells. In rat inner medullary duct cells, it has 
been shown that the Na+JH+ antiporter could be turned on by TPA and not by the analogue 
4 cx-phorbol (inactive form of TPA). The antiporter is amiloride-sensitive and the rise in 
pHi due to TPA was inhibited by amiloride. In light of all the data gathered in this study, 
Slotki et al. (1990) concluded that the regulation of the Na+JH+ antiporter in these cells 
involved PKC. Based on these studies, I have also chosen to examine the involvement of 
PKC in the regulation of the Na+ JH+ antiporter in Xenopus oocytes. 
PKC is not the only kinase thought to play a role in regulating the Na+JH+ antiporter. 
Ca2+-Calmodulin kinase also appears to be involved in the regulation of the Na+/H+ 
antiporter during fertilization of the sea-urchin eggs. The pHi rise during fertilization was 
partially blocked by a Ca2+-calmodulin inhibitor known as W-7 (Shen, 1989). Therefore, 
in sea-urchin eggs the Na+JH+ antiporter appears to be regulated by two kinases, protein 
kinase C and calcium-calmodulin kinase. In cultured cells like GH4C1 rat pituitary cells, 
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human cell line U937, porcine thyroid cells, and human platelets, it has been shown that an 
increase in free Ca2+ is necessary for the activation of the Na+JH+ antiporter. There are at 
least two ways that Ca2+ could be involved in regulating the Na+JH+ antiporter. First, 
calcium is necessary for PKC activation, and PKC could be involved in the regulation of 
the antiporter. Second, calcium could regulate the activity of the exchanger through 
Ca2+-calmodulin kinase in these cells (Tornquist et al., 1991; Alvarez et al., 1989; Takasu 
et al., 1989; Kimura et al., 1990). It seems that calcium-calmodulin kinase could be 
involved in regulating the Na+/H+ antiporter; therefore, in my study I also examined the 
potential role of this kinase in affecting an increase in pHi. 
Another kinase that has been proposed to be involved in regulating the Na+/H+ 
antiporter is cyclic AMP-dependent protein kinase, PKA. Not many cell systems are 
known for using PKA as a regulator of this exchanger. It has been observed in some cell 
systems that elevation of the cytoplasmic level of cAMP causes a reduction in the rate of 
the Na+JH+ antiporter (Grinstein and Rothstein, 1986). However, in murine macrophages 
and fish erythrocytes, it has been shown that elevation of cAMP due to cholera toxin or 
dibutyryl-cAMP could cause an increase in the activity of the exchanger. Therefore, PKA 
has been suggested to be involved in the regulation of the exchanger in these cells (Kong et 
al., 1989). Therefore, I also studied the potential role of PKA in regulating the Na+fH+ 
exchanger in Xenopus oocytes. 
When all three kinases stated above turned out to not be involved in the regulation of 
the Na+fH+ antiporter, I then investigated the potential role of other kinases that are 
activated during meiotic maturation (See Results, PARTII). As previously described, fully 
grown stage VI oocytes are naturally arrested in first meiotic prophase. Progesterone 
releases this arrest by activating a cascade of protein kinases that initiate germinal vesicle 
breakdown (GVBD) and meiotic maturation (reviewed by Smith, 1989). Maturation 
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promoting factor (MPF), a cytoplasmic kinase, is responsible for GVBD and chromosome 
condensation. This kinase is also responsible for nuclear membrane breakdown (NMBD) 
and chromosome condensation during mitosis in somatic cells (Sagata et al., 1989; 
Nebrada and Hunt, 1993). 
One of the most important events that occur during meiotic maturation is the activation 
of MPF from an inactive complex called pre-MPF which is stored in the cytoplasm of 
Xenopus oocytes (Nebrada and Hunt, 1993). MPF has two components: one is a 34kD 
polypeptide known as p34cdcZ, and the other is a 45kD polypeptide known as cyclin B 
(Roy et al., 1990). Oocytes treated with cycloheximide, a protein synthesis inhibitor, do 
not undergo GVBD in response to progesterone; therefore, a newly synthesized "initiator" 
protein is necessary for MPF kinase activation (Wasserman and Masui, 1975; Sagata et al., 
1989). The proto-oncogene product p39 c-mos kinase has been proposed to be the 
"initiatior" of oocyte maturation and activator of MPF from pre-MPF (Sagata et al., 1989). 
p39 c-mos is translated de nova upon progesterone stimulation; injection of mos mRNA or 
protein into oocytes induces their maturation in the absence of hormones. On the other 
hand, injection of antisense c-mos oligonucleotides blocks progesterone-induced GVBD 
(Daar et al., 1993). Microinjection of p39 c-mos protein into oocytes treated with 
cycloheximide is also sufficient to cause GVBD in the absence of progesterone (Yew et al., 
1992). These results indicate that the synthesis of p39 c-mos is not only necessary , but 
also sufficient for GVBD. p39 c-mos protein acts as a kinase within the oocyte. It has 
been shown in vitro and in vivo that p39 c-mos kinase can rapidly activate other 
downstream kinases, such as mitogen-activated protein kinase kinase (p45 MAP kinase 
kinase), p42 MAP kinase, and Raf-1 kinase (Posada and Cooper, 1992; Posada et al., 
1993; Nebrada and Hunt, 1993). All these kinases become activated during 
progesterone-induced maturation, but it has not yet been determined what roles they play 
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in the maturation pathway. 
Another event that has to occur for activation of MPF is a drop in cAMP and active 
PKA levels (Maller and Krebs, 1977; Schorderet-Slatkine et al., 1982; Maller, 1983). It is 
believed that cAMP-dependent protein kinase (PKA) acts as a negative regulator of the 
G2/M transition, and progesterone stimulation of the oocyte causes a decrease in cAMP 
levels which in tum leads to a decrease in PKA activity (Maller and Krebs, 1977; Sadler 
and Maller, 1981, 1987). The decrease in PKA activity may result in the 
dephosphorylation of a presumptive maturation-inhibiting phosphoprotein (Maller and 
Krebs, 1977; Daar et al., 1993). The role of cAMP/PKA in the maturation pathway is not 
clear, but a recent study has shown that PKA inhibits mos-induced GVBD in Xenopus 
oocytes (Daar et al., 1993). As described above, injections of c-mos mRNA or c-mos 
protein into oocytes causes GVBD in the absence of progesterone (Sagata et al., 1989). 
These results suggest that inactivation of PKA along with the promoting activities of c-mos 
kinase leads to MPF activation. Both events have to occur for MPF activation. The 
observation that cAMP/PKA will block c-mos-induced GVBD suggests that the inhibitory 
effect of PKA may be downstream of c-mos (Daar et al., 1993). 
One or more of the kinases active during maturation could play a role in regulating the 
Na+JH+ antiporter during progesterone-induced oocyte maturation. Preliminary studies 
have shown that microinjection of crude cytoplasm, taken from oocytes undergoing 
GVBD (a time when their Na+/H+ exchangers are fully activated), into immature 
non-hormone-treated stage VI oocytes will cause a rapid activation of the Na+/H+ pumps 
and GVBD in the recipient oocytes (Wasserman, unpublished data). Crude cytoplasm of 
stimulated maturing oocytes contains all the active kinases that were mentioned, plus 
others. Therefore, I investigated the possible role of p34-MPF kinase or p39 c-mos kinase 
in the regulation of the Na+fH+ antiporter during progesterone-induced maturation. 
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As previously stated, all vertebrate oocytes have to undergo meiotic maturation before 
they can become fertilized by sperm. The increase in pHi has to occur for a successful 
completion of meiotic maturation. If the pHi increase does not occur, then meiotic 
maturation will not occur which means that fertilization will not occur, and the animal will 
not be able to reproduce. Therefore, it is important to determine how this increase in 
intracellular pH is regulated. 
CHAPTER II 
MATERIALS and METHODS 
A Ovariectomy/Defolliculation/Oocyte culture: 
Female Xenopus laevis (NASCO, Ft. Atkinson Wis.) were anesthesized by 
hypothermia. A one cm incision was made in the ventral skin and muscle wall and ovarian 
fragments were removed. Full grown stage VI oocytes (Dumont, 1972) were isolated 
from the ovarian fragments by micro-dissection. The ovarian epithelium and collagen 
layers surrounding each oocyte were manually removed with Dumont #5 watchmaker's 
forceps. This process is called defolliculation. NOTE: Enzymatic removal of the ovarian 
epithelium was not used in this step because of the disruption and damage to oocyte 
surface proteins including the Na+/If+ antiporter (Towle et al., 1990). All incubations of 
oocytes were carried out in OR-2 medium (82.3mM NaCl, 2.5mM KCl, 1.0mM CaC12, 
1.0mM MgC12, 5mM Hepes, 1.0mM Na2 HP04, pH 7.6) (Wallace et al., 1973). 
B. pHi Measurement: 
Oocyte pHi measurements were determined using the weak acid, 14C-DMO, 
14C-Dimethyloxazolidine 2,4 dione (NEN) (Wadell and Butler, 1959). 14C-DMO in its 
uncharged form can cross the plasma membrane of the oocyte. A DMO equilibrium is 
established across the cell membrane according to the extracellular and intracellular pH 






H + + 14C-DMO - + 14 H + C-DMO 
Figure 1. DMO equilibration across the oocyte plasma membrane. Oocytes were 
incubated in 14C-DMO (0.25µCi/ml) for 2.5 hours at 20°C to allow for equilibration. The 
equilibrium of DMO across the cell membrane will be established according to the 
extracellular pH (pHe) and intracellular pH (pHi) environments. 
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oocytes (Houle and Wasserman, 1983). 2.5µ1 of 14C-DMO were placed in tubes and 
dryed under N2 to remove the ethyl acetate solvent (stock 50µCi/500µ1). For each pHi 
experiment 14C-DMO was resuspended in 1.0ml of OR-2 or the desired medium and 
vortexed. The contents of the tube were transferred into 2ml multiwell dishes. The final 
concentration of 14C-DMO in each well was 0.25µCi/ml. For each treatment, 20 oocytes 
were placed in a well and labelled. After 2.5hrs of incubation in 14C-DMO at 20°C, 
desired drugs or hormones were added. The oocytes were incubated with the drug or 
hormone for the desired time (usually 2-17hrs depending on the experiment). 
After the appropriate incubation period, media and oocyte 14C-DMO concentrations 
were determined. In triplicate, 10µ1 of the medium were removed, placed in scintillation 
vials and lOml of BCS (Aqueous Biodegradeable Counting Scintillant, Amhersham) were 
added to each vial. In triplicate, groups of five oocytes at a time were removed from the 
well and washed quickly in 3 dishes of non-radioactive medium (lOsec, 30ml per dish), 
then placed in a scintillation vial and excess fluid was removed using a pasteur pipette. 
NCS (tissue solubilizer, Amhersham), 0.5ml, was added to the vials and placed in a 60°C 
incubator for 30 minutes until all of the oocytes were digested. The vials were removed, 
cooled to -20°C for 5 minutes, then lOml of cold BCS-NA (non-aqueous scintillation 
cocktail, Amersham) were added to the vials and mixed. The media and oocyte vials were 
counted in a Beckman LS-7000 liquid scintillation counter. CPM data from the counter 
were converted to DPM and this was used to calculate the pHi by using the following 






pHi = pKa +Log( fDMOJ inside (lOpHe-pKa +l) -1) 
[DMO] outside 
= intracellular pH 
=external pH (OR-2) = 7.60 
=6.32 
= concentration of DMO inside the oocyte 
= DPM/µl (water volume of a stage VI oocyte is 0.45µ1) 
=concentration of DMO outside the oocyte (medium) 
=DPM/µl 
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For most pHi experiments, there was one basic experimental design: control ( oocytes 
with no treatment); control + kinase inhibitor or kinase activator; progesterone; 
progesterone + kinase inhibitor or kinase activator, and kinase activator + kinase inhibitor. 
C. Microinjection of Peptides: 
In a portion of my study I used peptides that do not diffuse across the plasma 
membrane and had to be microinjected. Microinjection needles were constructed from glass 
capillaries using a De-Fonbrune microforge. The needles were designed to deliver 20 or 
40nl per oocyte through a lOµm tip opening. The microinjection needle delivered peptides 
into a single site within the oocyte cytoplasm. 
D. Electroporation of Peptides: 
Single site injection may not be adequate for diffusion of the peptides throughout the 
oocyte cytoplasm. Therefore, electroporation was used in an attempt to introduce peptides 
at multiple sites. Electroporation has not been described in the literature for Xenopus 
laevis oocytes. Initial studies were carried out to see if I could successfully electroporate 
Xenopus oocytes (test compound A TP32). Electroporation was carried out in calcium-free 
OR-2. The voltage varied from 125 to 150volt/cm. Varied pulse lengths were also used 
(0.2-46ms). The setting that gave maximal survival of the oocytes and maximal entry of 
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the test compound was used for peptide electroporation into Xenopus oocytes. The 
voltage was set at 125volt/cm, the capacitance at 330µF, and pulse length at 0.6ms. 
E. Experimental Desiim: 
The question asked is how does progesterone stimulate the Na+JH+ antiporter during 
oocyte maturation? There are two alternative hypotheses; 
Hypothesis I: The Na+/H+ antiporter is regulated by phosphorylation. Progesterone 
stimulates the antiporter by activating a protein kinase (or kinases) 
which are involved in regulation of the antiporter. 
Hypothesis II: The Na+/H+ antiporter is regulated by a non-phosphorylation event. 
According to studies on other cell systems, this mechanism is less 
likely to occur. 
The most direct way of investigating whether phosphorylation of the exchanger takes 
place inXenopus oocytes would be to study the NHE protein (Na+/H+ Exchanger protein) 
using 32P-orthophosphate-labelled oocytes with Western blot analysis or 
immunoprecipitation. However, these experiments were not performed since a mammalian 
NHE-1 antibody does not cross react with the Xenopus peptide (Jacques Pouyssegur, 
personal communication, August 1992). Thus, I used an indirect approach to look at 
potential kinases that could be involved in regulating the exchanger in Xenopus oocytes 
during progesterone induced oocyte maturation. 
According to studies done on other cell systems, three potential kinases should be 
examined; protein kinase C (PKC), calcium-calmodulin kinase, and cAMP 
dependent-kinase (PKA). These kinases were artificially activated and inhibited in 
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progesterone-treated stage VI oocytes, and the Na+JH+ antiporter activity (pHi) of the 
oocytes was measured. Two potential outcomes are listed below: 
1) If an activator of a specific kinase in the absence of progesterone stimulates the 
Na+JH+ antiporter and the respective inhibitor of that kinase inhibits progesterone 
stimulation of the exchanger, then hypothesis I is supported. 
2) If activators of kinases in the absence of progesterone have no effect on the Na+JH+ 
antiporter and respective inhibitors of kinases have no effect on progesterone 
stimulation of the exchanger, then hypothesis II is supported. 
At the end of this study a conclusion may be drawn with regard to which of the three 
kinases may be involved in regulating the Na+JH+ antiporter in Xenopus oocytes. The 
other possibility that should be mentioned is that more than one kinase could be involved in 
regulating the exchanger in Xenopus oocytes, as is the case in sea-urchin eggs. There is 
also the possibility that another kinase not listed above could be involved in the regulation 
of the exchanger (see Results and Discussion sections). 
F. Activation and Inhibition of Three Different Kinases: 
1. Protein kinase C 
a) Activation of PKC: 
Protein kinase C was first investigated because this kinase appears to be 
involved in regulating the Na+JH+ antiporter in numerous cell systems. Protein kinase C 
was activated with 12-0-tetra decanoyl phorbol 13-acetate (phorbol ester or TPA, 
Gibco/BRL). 4p-TPA binds to the DAG site on PKC and increases the affinity of PKC for 
Ca2+, thereby activating PKC at physiological calcium concentrations (Nishizuka, 1984). 
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(1) TPA Dose Response--oocytes were treated with different doses of 4~-TPA 
(lOOnM, 200nM, 400nM, 800nM, and 1600nM) for 12-14 hours. The lowest dose that 
gave a ~0.2 rise in pHi was chosen for further experiments. 4~-phorbol ester (TPA) has 
an inactive isomer 4a-TPA (4a-12-0-tetra decanoyl phorbol 13-acetate) which does not 
activate PKC, and it serves as a negative control. Oocytes were treated with 1600nM of 
inactive 4a-TPA and pHi was measured. 
(2) pHi Kinetics--oocytes were treated with 4~-TPA or progesterone (lµM) for 
2, 4, or 6 hours and pHi was measured at each time point. It has previously been shown 
that stage VI oocytes undergo a ~0.3-0.4 unit increase in pHi and GVBD within 5-6 hours 
following progesterone stimulation (Houle and Wasserman, 1983). pHi response curves 
for 4~-TPA and progesterone were compared. Shorter time points of 30min, lhr, 1.5hr, 
and 2hrs were also examined. 
b) Inhibition of protein kinase C: 
The PKC inhibitors that were used were H-7 (Sigma), staurosporine (Sigma), 
and PKC(19-36) (Gibco/BRL). These inhibitors were used at or above the concentrations 
reported in different studies (Kwon and Lee, 1991; Stith et al., 1992; Shen and Buck, 
1990; Kroll et al., 1991). H-7 competes with ATP for the catalytic site of PKC (Hidaka et 
al., 1984). Oocytes were pre-incubated in H-7 (100 or 200µM) + 14C-DMO for 12-14 
hours, then 4~-TPA, or progesterone (lµM) was added to the wells. After 2-8 hours of 
incubation, the oocytes pHi was measured and compared. 
Staurosporine binds to the non-catalytic site of PKC (Tamaoki et al., 1986). Oocytes 
were pre-incubated in staurosporine (50-lOOnM) + 14C-DMO for 12-14 hours, then 
4~-TPA, or progesterone was added. Oocytes were incubated for 2-8 hours, then their pHi 
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was measured. 
PKC(l9-36) is a synthetic peptide of the autoregulatory pseudosubstrate domain of 
PKC. The inhibitor occupies the active site of PKC in the absence of effector molecules 
(4~-TPA or DAG, House and Kemp, 1987). This inhibitor has to be microinjected or 
electroporated into cells. PKC(l9-36) dissolved in OR-2 at a peptide concentration of 
3mM was microinjected into the oocytes at 20 or 40nVcell. The final concentration of the 
inhibitor within the oocytes was 40 or 80µM. After injection, the oocytes were incubated 
in 14C-DMO for 12-14 hours, then treated with progesterone or 4~-TPA. pHi was 
determined for each treatment after 2-8 hours of incubation with the drugs. 
2. Calcium-calmodulin kinase 
a) Activation of calcium-calmodulin kinase: 
Microinjected calmodulin (Calbiochem) saturated with bound calcium ions was 
used as the calcium-calmodulin kinase activator. This activator was used at or above the 
concentrations reported in literature (Wasserman and Smith, 1981). Calmodulin was 
injected into the oocytes at 40nVcell. The final amount of the activator within the oocyte 
was 100 or 400ngs. After microinjection, the oocytes were incubated in 14C-DMO for 
12-14 hours, then treated with progesterone for 8 hours or left untreated before their pHi 
was measured. 
b) Inhibition of calcium-calmodulin kinase: 
The two calcium-calmodulin kinase inhibitors that were used were 
trifluroperizine (TFP, Janssen) and calmidazolium (Janssen). These two inhibitors were 
used at or above the concentrations suggested in other studies (Bomslaeger et al., 1984; 
Van Belle, 1981). TFP and calmidazolium bind to the hydrophobic region of calmodulin 
inhibiting the binding of calmodulin with target enzymes (Tanaka and Hidaka, 1980; 
Hidaka, 1981). Incubation in these inhibitors is sufficient for the drugs to get into the 
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cells. TFP was used at lOOµM and calmidazolium at 1 to lOµM. The oocytes were 
pre-incubated in the inhibitors+ 14C-DMO for 12-14 hours, then the oocytes were treated 
with progesterone for 8 hours. Oocyte pHi was measured and compared. 
3. cAMP-dependent kinase (PKA) 
a) Activation of PKA: 
The activators of PKA that were used were forskolin (Sigma), which stimulates 
the synthesis of cAMP by adenylate cyclase, isobutylmethylxanthine (IBMX) and 
theophylline (Sigma) which inhibit phosphodiesterases that degrade cAMP in Xenopus 
oocytes (Maller and Krebs, 1977). These activators were used at or above the 
concentrations reported in different studies (Maller and Krebs, 1977; Maller, 1983; 
Bomslaeger et al., 1986). Forskolin was used at 10 to lOOµM; IBMX and theophylline 
were used at 0.1 to 5mM. Oocytes were incubated in the activators + 14C-D M 0 for 12-14 
hours, then oocytes were treated with progesterone (8 hours) or left untreated before their 
pHi was determined. If PKA is not involved in the regulation of the Na+fH+ antiporter in 
Xenopus oocytes, then other kinases should be examined. 
G. Evidence for Sodium/Hydrogen Antiporter Stimulation: 
Previous experiments have shown the pHi increase in response to progesterone is due 
to the Na+/H+ antiporter (Wasserman and Houle, 1984). To ensure that any pHi rise 
measured under all treatments in this study was the result of the stimulation of the Na+/H+ 
antiporter, the exchanger was specifically inhibited with amiloride (3,6-diamino-6-chloro-
N-diaminomethylene pyrozinicarboxamide monohydrochloride). This drug is a diuretic 
drug which acts as a specific inhibitor of the Na+fH+ exchange pathway (Towle et al., 
1990). 
Oocytes were pretreated with amiloride (l0-8 to 10-3M) for 12-14 hours, and 
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subsequently were treated with progesterone or kinase activators in the presence of 
amiloride + 14C-DMO. After 2-8 hours incubation with the drugs, oocytes pHi was 
measured. A rise in pHi caused by kinase activators is not inhibited by amiloride, then one 
can conclude that the kinase stimulation of an exchanger that is not normally used to 
regulate pHi in Xenopus during oocyte maturation. 
H. Statistical Analysis: 
For each treatment and time point in an experiment, 15 oocytes (three groups of five 
oocytes each) were used to measure the oocyte pHi in triplicate. Experiments were 
replicated using oocytes from a minimum of 3 different animals on 3 different days (n=3). 
All pHi values are the mean of pHi ± S.E. of the mean. The data were analyzed by using 
Randomized block ANOV A. When a significant F-value was encountered, different 
treatments were compared using Tukey's multiple test comparison. The 6-DMAP data 
were first transformed using log(%GVBD+l) or log(%~pHi+l), then fitted to a straight 
line (See Results). The slopes of least-squares fitted regression lines were then compared 




PART I: Protein Kinase C. Ca-Calmodulin Kinase. and Protein Kinase A 
A. Protein kinase C: 
Protein kinase C was the first kinase investigated because in numerous cell systems it 
appears that PKC may be involved in regulating the Na+fH+ antiporter. Studies done by 
Stith and Maller (1987) showed that 4~-TPA, an artificial activator of PKC, at 1600nM, 
can cause a pHi increase of .::10.2 in Xenopus oocytes implying that PKC could be involved 
in regulating the Na+/H+ antiporter. However, this study did not indicate if the pHi 
increase in response to 4~-TP A was in fact due to the stimulation of the Na+ /H+ antiporter. 
Therefore, I wanted to verify their 4~-TP A result and also determine if the increase in pHi 
is in fact due to the stimulation of the Na+fH+ antiporter. However, my main focus was to 
determine if pro~esterone uses PKC to regulate the Na+/H+ antiporter during oocyte 
maturation. 
PKC was first activated artificially using 4~-TPA. The inactive isomer of TPA, 
4a.-TP A was used as a negative control. Secondly, three different PKC inhibitors were 
used to see if they have any effect on progesterone stimulation of the Na+/H+ antiporter. 
1. Activation of protein kinase C: 
a) TP A Dose Response Curve--based on doses of 4~-TP A reported in the literature 
(Stith and Maller, 1987; Slotki et al., 1990; Mitsuka and Berk, 1991; Kwon and Lee, 
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1991), various concentrations of 4~-TPA ranging from lOOnM to 1600nM were used to 
treat the oocytes for 12-14 hours. As shown in Figure 2, a il0.2 increase in pHi was 
obtained with a 4~-TPA dose of 400nM and higher. This experiment showed that the 
active form of 4~-TP A can cause a maximum il0.2-0.25 increase in pHi and there is no 
further increase in pHi by increasing the dose to 1600nM. Pigment in the animal pole 
cortex of the oocytes treated with 800 and 1600nM 4~-TP A became internalized; however, 
at 400nM 4~-TP A the oocytes looked better and still underwent a il0.2 unit increase in 
pHi. Therefore, 4~-TPA at 400nM was used for further experiments. The inactive form 
of TPA ( 4a.-TPA) used at the highest dose of 1600nM, however, did not cause an increase 
in pHi (Fig. 2), nor did it affect the oocyte pigmentation pattern. 
b) pHi Kinetics--progesterone-induced GVBD inXenopus oocytes takes place within 
5-6 hours after the steroid is added, and a il0.3-0.4 unit increase in pHi is completed 
around the same time (Houle and Wasserman, 1983; Stith and Maller, 1984). I was 
interested in determining how quickly 4~-TP A can cause the pHi change in comparasion to 
progesterone. Initial experiments, treating oocytes with 4~-TPA for 2, 4, or 6 hours, 
showed that the maximum increase in pHi is obtained by 2 hours, and there is no further 
increase in pHi by increasing the exposure time to 4~-TP A and in fact the pHi increase is 
smaller after 6 hours (Data not shown). Therefore, I looked at the shorter time points 
between 0 to 2 hours. Oocytes were treated with 4~-TPA (400nM) or progesterone (lµM) 
and pHi measurements were determined every 30 minutes up to 2 hours. Figure 3 shows 
that a il0.13 increase in pHi can be detected in 4~-TPA-treated oocytes within 30 minutes, 
while there is no increase in pHi in progesterone-treated oocytes (il-0.04). This result 











Figure 2. 4~-TP A induced an increase in oocyte pHi. A preliminary study was done to 
find the lowest dose of 4~-TP A that induced an increase in oocyte pHi. Oocytes were 
pre-incubated in OR-2 medium containing 14C-DMO for 2 hours and either left untreated 
(Cont) or treated with progesterone (lµM) or4~-TPA (100-1600nM) for 12-14 hours. A 
..1.0.2 increase in pHi was obtained with a 4~-TP A dose of 400nM or higher. The inactive 
form of TPAi (4a-TPA) at 1600 nM did not cause a pHi increase. This is the result of an 
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Figure 3. 4~-TPA rapidly induced an increase in oocyte pHi. Oocytes were pre-incubated 
in OR-2 medium containing 14C-DMO and then treated with progesterone (lµM) or 
4~-TPA (400nM) for 30 minutes, 1hr,1.5 hr, and 2 hrs. pHi was measured at each time 
point. The progesterone data are identical to the results previously reported in the literature 
(Houle and Wasserman, 1983); therefore, the experiment was not replicated. The 4~-TPA 
data are expressed as mean ± SEM, where n=3. 
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c) Amiloride--to confirm that the increase in pHi detected in response to progesterone 
and 4p-TP A was due to activation of the Na+/H+ antiporter, the oocytes were treated with 
amiloride which acts as a specific inhibitor of the Na+/H+ exchanger. First a proper dose 
of amiloride that would effectively block the Na+JH+ antiporter stimulation was 
determined. Oocytes were pre-treated with amiloride at 10-8M to 10-3M for 12-14 hours 
and then progesterone (lµM) was added to the medium. As shown in Figure 4, amiloride 
at 6x 10-6M inhibited the steroid activation of the exchanger by 50 percent (IC50). The 
increase in pHi in response to progesterone was completely blocked at lmM amiloride (p < 
0.001). Similar results were observed by Towle et al. (1991). In their study it was found 
that 22Na+ influx and H+ efflux via the Na+/H+ antiporter in non-hormone-treatedXenopus 
oocytes was inhibited 50 percent by 4x10-6M amiloride. To ensure that the pHi increase in 
response to 4p-TPA was due to activation of the Na+/H+ antiporter, lmM amiloride was 
used to inhibit the Na+/H+ antiporter. Oocytes were pre-treated with lmM amiloride for 
12-14 hours and then progesterone ( 1 µM) or 4p-TP A ( 400nM) was added to the medium. 
As shown in Figure 5, progesterone caused an increase in pHi from 7.26 ± 0.05 to 7.71 ± 
0.06 at the time of GVBD. 4p-TPA treatment resulted in an increase in pHi from 7 .26 ± 
0.05 to 7.56 ± 0.04 without causing GVBD. However, lmM amiloride completely 
blocked the ability of progesterone or 4p-TP A to increase the pHi of the oocyte (p < 
0.001). These observations confirm previous results that the pHi increase seen during 
progesterone-induced oocyte maturation is due to the stimulation of the Na+/H+ antiporter. 
Furthermore, the 4p-TP A induced increase in pHi also appears to be due to the activation 
of the Na+/H+ antiporter. 
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Figure 4. Amiloride blocked the progesterone-induced increase in oocyte pHi. Oocytes 
were pre-incubated in OR-2 medium containing 14C-DMO in the presence or absence of 
amiloride (l0-8 to 10-3 M) for 12-14 hours and then treated with progesterone (lµM). The 
pHi was determined after 8 hours. Fifty percent inhibition of the steroid activation of the 
Na+fH+ antiporter occured with 6x10-6M amiloride. The data are expressed as mean± 
SEM, where n=3. 
28 
7.9 
• -Amiloride 7.8 c 
• +Amiloride 7.7 
7.6 





Cont TPA Prog 
Figure 5. Amiloride blocked progesterone-and 4~-TPA-induced increase in oocyte pHi. 
Oocytes were pre-incubated in OR-2 medium containing 14C-DMO for 12-14 hours in the 
presence or absence of arniloride (lmM) and either left untreated for 6 hours (Cont) or 
treated with 4~-TPA (400nM) or progesterone (lµM) for 2 or 8 hours respectively. 
Arniloride significantly inhibited progesterone-and 4~-TPA-induced increase in pHi (p < 
0.001). Columns with different letters above them are significantly different from each 
other using Tukey's multiple test comparison. The data are expressed as mean ± SEM, 
where n=3. 
29 
In addition 4~-TP A can activate the exchanger much faster than progesterone. However, it 
is still not known if progesterone normally uses PKC to activate the Na+JH+ antiporter 
during oocyte meiotic maturation. Therefore, PKC inhibitors were used to see if they have 
any effect on the steroid activation of the exchanger during normal oocyte meiotic 
maturation. 
2. Inhibition of protein kinase C: 
Three protein kinase C inhibitors having different potencies and specificities were 
used to inhibit PKC. They were H-7, staurosporine and PKC(19-36). Preliminary 
studies done with these PKC inhibitors showed no effect on 4~-TPA's (400nM) ability to 
stimulate the exchanger; therefore, the dose of 4~-TP A was reduced from 400 to 250nM to 
prevent the activator from possibly overpowering the inhibitor of PKC. However, before 
the new concentration of 4~-TP A was used, experiments were done to make sure that the 
new 4~-TP A dose could still stimulate the exchanger. As shown in Figure 6, 4~-TP A at 
250nM caused a ~0.3 unit increase in pHi within 4 hours. Therefore, 250nM 4~-TPA was 
used in the following PKC inhibitor experiments. 
Oocytes were pre-incubated in H-7 at concentrations ranging from 100 to 200µM, and 
then the oocytes were treated with progesterone (lµM) or 4~-TPA (250nM). Figure 7 
shows that H-7 at 200µM did not block progesterone or 4~-TPA activation of the 
exchanger nor did it have a significant effect on pHi by itself. There is no significant 
difference in the pHi of the oocytes treated with or without H-7 (p > 0.5). 
Staurosporine, a more specific and potent inhibitor of PKC, was used at 100 or 
200nM. The oocytes were pre-treated with staurosporine for 14 hours before progesterone 
(lµM) or 4~-TPA (250nM) addition. As shown in Figure 8, staurosporine did not inhibit 
progesterone or 4~-TPA activation of the exchanger (p > 0.5) nor did it stimulate or inhibit 















Figure 6. A lower dose of 4~-TPA could still significantly stimulate the Na+fH+ anti.porter. 
Oocytes were pre-incubated in OR-2 medium containing 14C-DMO and either left untreated 
(Cont) or treated with 4~-TP A (250nM) for 4 hours or progesterone for 8 hours. A il0.3 
unit increase in pHi was observed within 4 hours. There was no significant difference in 
4~-TP A or progesterone stimulation of the pump (p > 0.5). Columns with different letters 
above them are significantly different from each other using Tukey's multiple test 
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Figure 7. H-7, a PKC inhibitor, did not block progesterone or 4~-TPA activation of the 
Na+JH+ antiporter. Oocytes were pre-treated for 12-14 hours in OR-2 medium containing 
14C-DMO with or without H-7 (200µM) and either left untreated (Cont) or treated with 
4~-TPA (250nM) or progesterone ( lµM). The pHi was determined 4-8 hours later. There 
is no significant effect of H-7 on progesterone or 4~-TPA activation of the Na+JH+ 
antiporter (p > 0.5). Columns with different letters above them are significantly different 
from each other using Tukey's multiple test comparison. The data are expressed as mean 
± SEM, where n=3. 
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Figure 8. Staurosporine, a PKC inhibitor, did not block progesterone or 4~-TP A 
activation of the Na+JH+ antiporter. Oocytes were pre-treated for 12-14 hours in OR-2 
medium containing 14C-DMO with or without staurosporine (200 nM) and either left 
untreated (Cont) or treated with 4~-TPA (250 nM) or progesterone (lµM) for 4 or 8 hours 
respectively before the pHi was determined. Staurosporine had no significant effect on 
progesterone or 4~-TPA activation of the exchanger (p > 0.5). Columns with different 
letters above them are significantly different from each other using Tukey's multiple test 
comparison. The data are expressed as mean ± SEM, where n=4. 
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Both H-7 and staurosporine were dissolved in a solvent that was not appropriate for 
microinjection studies; therefore, they were added to the medium. However, a more 
selective peptide inhibitor of PKC known as pseudosubstrate PKC(19-36) was dissolved 
in OR-2 medium and microinjected into the oocytes. This inhibitor was microinjected into 
the cytoplasm at one site, multiple sites, and it was even electroporated across the cell 
membrane. In all cases, the results were similar. As shown in Figure 9, there was no 
significant effect on pHi. in oocytes injected with or without the peptide inhibitor at a final 
internal concentration of 80µM. PKC(19-36) did not stimulate or inhibit the exchanger by 
itself nor did it block progesterone or 4~-TP A activation of the exchanger (p > 0.5). 
Based on these results from three different PKC inhibitors, I conclude that PKC does 
not appear to be involved in the activation of the Na+fH+ antiporter during progesterone 
induced oocyte meiotic maturation. 4~-TPA may artificially activate the exchanger (See 
Discussion); however, it appears that PKC is not the kinase which regulates the exchanger 
during progesterone induced maturation. Since protein kinase C has been eliminated, a 
second kinase namely calcium-calmodulin kinase was investigated. 
B. Calcium-calmodulin kinase: 
During fertilization of sea urchin eggs, it has been shown that the egg Na+/tt+ 
antiporter can be regulated by PKC and by calcium-calmodulin kinase (Shen, 1989; Shen 
and Berk, 1990). Since other cell systems also use calcium and calmodulin to regulate 
their Na+/H+ antiporter (Alvarez et al., 1989; Takasu et al.; 1989; Tornquist and Tashijian, 
1991), calcium-calmodulin kinase was investigated as a potential regulator of the 
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Figure 9. PKC (19-36), a pseudosubstrate PKC inhibitor, did not block progesterone or 
4~-TPA activation of the Na+fH+ antiporter. Oocytes were pre-treated for 12-14 hours in 
OR-2 medium containing 14C-DMO. Oocytes were microinjected with PKC (19-36) (final 
internal concentration of 80µM) or left uninjected. Then, oocytes were either left untreated 
(Cont) or treated with 4~-TPA (250 nM) or progesterone (lµM) for 4 or 8 hours 
respectively before pHi was determined. PKC (19-36) had no significant effect on 
progesterone or 4~-TPA activation of the Na+fH+ antiporter (p > 0.5). Columns with 
different letters are significantly different form each other using Tukey's multiple test 
comparison. The data are expressed as mean ± SEM, where n=3. 
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1. Activation of calmodulin kinase: 
Calmodulin saturated with bound calcium ions was used to activate endogenous 
calmodulin kinase in vivo. The final amount of calmodulin microinjected into the oocyte 
was 100 or 400ngs. Figure 10 shows that calcium-calmodulin at 400ngs did not have any 
stimulatory effect by itself nor did it inhibit the steroid activation of the Na+/H+ antiporter 
(p > 0.5 ). 
2. Inhibition of calmodulin kinase: 
I also attempted to inhibit calcium-calmodulin kinase within the oocyte using 
trifluroperazine (TFP). Oocytes were pre-treated with TFP at lOOµM for 12-14 hours 
prior to progesterone treatment. As Figure 11 indicates, TFP did not stimulate the 
exchanger by itself nor did it block progesterone activation of the exchanger (0.05 < p < 
0.1). Similar results were obtained with a more potent and specific inhibitor of calmodulin 
kinase, calmidazolium (Figure 12). Pre-incubation of oocytes with calmidazolium at 1 to 
lOµM before progesterone treatment did not have any effect on progesterone stimulation of 
the exchanger (p > 0.5). 
Based on the calmodulin inhibitor and activator studies, calcium-calmodulin kinase 
does not appear to be involved in regulating the antiporter during progesterone induced 
oocyte meiotic maturation. Therefore, the potential role of a third kinase, cAMP protein 
kinase (PKA), was investigated. 
C. Protein kinase A: 
In a few studies using other cell systems, it has been shown that an elevation in cAMP 
can cause an increase in the Na+/H+ antiporter activity, indicating that PKA may be 
involved in regulating the exchanger in those cells (Kong et al., 1989; Weinman et al., 
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Figure 10. Ca2+-calmodulin, a calmodulin kinase activator, did not stimulate or block the 
steroid-induced activation of the Na+/H+ antiporter. Oocytes were pre-incubated in OR-2 
medium containing 14C-DMO, then the oocytes were either microinjected with 400 ngs of 
calmodulin with bound calcium or left uninjected for 12-14 hours. Then, the oocytes were 
either left untreated (Cont) or treated with progesterone (lµM). The pHi was determined 
after 8 hours. Calcium-calmodulin did not have a significant effect on 
progesterone-induced activation of the Na+JH+ antiporter (p > 0.5). The columns with 
different letters above them are significantly different from each other using Tukey's 
multiple test comparison. The data are expressed as mean± SEM, where n=3. 
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Figure 11. Trifluroperazine, a calmodulin kinase inhibitor, did not block the progesterone 
activation of the Na+/H+ antiporter. Oocytes were pre-incubated in OR-2 medium 
containing 14C-DMO for 12-14 hours with or without TFP (100 µM). Oocytes were either 
left untreated (Cont) or treated with progesterone (lµM). The pHi was determined 8 hours 
later. TFP had no significant effect on progesterone stimulation of the exchanger (0.05 < p 
< 0.1). The columns with different letters above them are significantly different from each 
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Figure 12. Calmidazolium, a specific calmodulin kinase inhibitor, did not block 
progesterone stimulation of the Na+fH+ antiporter. Oocytes were pre-incubated in OR-2 
medium containing 14C-DMO for 12-14 hours with or without calmidazolium (10 µM) and 
then either left untreated (Cont) or treated with progesterone for 8 hours before the pHi was 
determined. Calmidazolium did not have a significant effect on progesterone stimulation of 
the exchanger (p > 0.5). The columns with different letters above them are significantly 
different from each other using Tukey's multiple test comparison. The data are expressed 
as mean ± SEM, where n=4. 
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1990; Borgese et al., 1992; Guizouarn et al., 1993) . Therefore, I chose to study the 
potential role of PKA in regulating the Na+/H+ antiporter in Xenopus oocytes during 
meiotic maturation. 
1. Activation of PKA: 
cAMP levels within the oocyte cytoplasm were increased by either stimulating the 
synthesis of cAMP by the enzyme adenylate cyclase, or inhibiting the degradation of 
cAMP by phosphodiesterases. Oocytes were pre-treated with forskolin, an adenylate 
cyclase stimulator, at concentrations ranging from 10 to lOOµM before progesterone 
treatment. Figure 13 shows that forskolin at lOOµM had a significant inhibitory effect on 
progesterone's ability to activate the exchanger (0.001 < p < 0.005). Similar results were 
obtained when cAMP-phosphodiesterases were inhibited using theophylline or IBMX at 
doses ranging from 0.1 to 5mM. As shown in Figures 14 and 15, both drugs at 5mM 
significantly inhibited progesterone's ability to activate the exchanger (p < 0.001). These 
results suggest that elevated cAMP/PKA are antagonistic to the activation of the Na+/H+ 
antiporter. Kahn et al. (1985) have also shown that elevated levels of cAMP inhibit the 
Na+/H+ antiporter in rabbit brush border membrane vesicle. 
Elevated levels of cAMP/PKA appear to be antagonistic to progesterone's activation of 
the Na+/H+ antiporter. The PKA results may suggest that the exchanger is regulated via a 
dephosphorylation mechanism. However, no other study has indicated that 
dephosphorylation will activate a Na+/H+ antiporter. Since PKA seemed not to be 
involved in activation of the antiporter, I expanded my research to investigate other kinases 
known to be activated during oocyte maturation for their potential role in regulating the 
Na+m+ antiporter in Xenopus oocytes. 
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Figure 13. Forskolin, an activator of adenylate cyclase, antagonized the progesterone 
activation of the exchanger. Oocytes were pre-incubated in OR-2 medium containing 
14C-DMO for 14 hours with or without forskolin (100 µM) and either left untreated (Cont) 
or treated with progesterone (lµM) for 8 hours before the pHi was determined. Forskolin 
had a significant inhibitory effect on progesterone stimulation of the Na+JH+ antiporter 
(0.001 < p < 0.005). Columns with different letters above them are significantly different 
from each other using Tukey's multiple test comparison. 
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Figure 14. Theophylline, a cAMP phosphodiesterase inhibitor, antagonized progesterone 
activation of the exchanger. Oocytes were pre-incubated in OR-2 medium containing 
14C-DMO for 12-14 hours with or without theophylline (5 rnM) and either left untreated 
(Cont) or treated with progesterone (lµM) for 8 hours before the pHi was determined. 
Theophylline significantly inhibited progesterone stimulation of the Na+fH+ antiporter (p < 
0.001). Columns with different letters above them are significantly different from each 
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Figure 15. IBMX, a cAMP phosphodiesterase inhibitor, antagonized the progesterone 
activation of the exchanger. Oocytes were pre-incubated in OR-2 medium containing 
14C-DMO for 12-14 hours with or without IBMX (5 mM) and either left untreated (Cont) 
or treated with progesterone (lµM) for 8 hours before the pHi was determined. IBMX 
had a significant effect on progesterone stimulation of the Na+/H+ antiporter (p < 0.001). 
Columns with different letters above them are significantly different from each other using 
Tukey's multiple test comparison. The data are expressed as mean ± SEM, where n=4. 
PART II: Other Kinases Activated Durin& Oocyte Maturation 
A. p34 MPF Kinase: 
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p34 MPF is one of the most important kinases that becomes active during progesterone 
-induced oocyte maturation (Nebrada and Hunt, 1993). p34 MPF kinase is responsible for 
germinal vesicle breakdown (GVBD) and chromosome condensation in oocytes (Gautier et 
al., 1988). Since p34 MPF kinase becomes active during oocyte maturation, there is the 
possibility that p34 MPF kinase could also play a role in regulating the Na+/H+ antiporter 
during progesterone- induced oocyte maturation. Therefore, I attempted to inhibit p34 
kinase using 6-DMAP (6-dimethylaminopurine), which can reversibly inhibit p34 MPF 
kinase (Jessus et al., 1991; Kalous et al., 1993), to see what effect, this had on the steroid 
activation of this exchanger. Oocytes were pre-treated with various doses of 6-DMAP 
ranging from 0.063mM to 0.25mM + 14C-DMO for 12 to 14 hours and then progesterone 
(lµM) was added to the medium. Oocytes were monitored for GVBD and pHi after 8 
hours treatment with progesterone. The data were analyzed using comparasion of two 
slopes (See Materials and Methods), and the results indicated that 6-DMAP had an 
inhibitory effect on both GVBD and on pHi (Figures 16,17). However, it seems that 
6-DMAP had a greater inhibitory effect on GVBD (p < 0.001) than on pHi (0.01 < p < 
0.02). At 0.063mM, 6-DMAP inhibited GVBD by 70% (Fig. 16), but it had no effect on 
pHi (Fig. 17). At 0.25mM, GVBD was completely blocked (Fig. 16), but pHi was only 
slightly inhibited (Fig. 17). From these results, I tentatively concluded that p34 MPF 
kinase may not be involved in the regulation of the Na+fH+ antiporter (See Discussion). 
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Figure 16. 6-DMAP, an inhibitor of p34 MPF kinase, completely inhibited MPF-induced 
GVBD in progesterone treated oocytes. Oocytes were pre-incubated in OR-2 medium 
containing 14C-DMO for 12-14 hours with or without 6-DMAP at 0, 0.063, 0.125, or 
0.25 mM. Oocytes were either left untreated (Cont) or were treated with progesterone 
(lµM). GVBD was monitored 8 hours later. 6-DMAP significantly inhibited GVBD in 
progesterone treated oocytes (p < 0.001). The results were analyzed using slope of the 
line (Zar, 1984). Data points without error bars represent data that were identical for all 
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Figure 17. 6-DMAP, a p34 MPF kinase inhibitor, had a slight inhibitory effect on the 
upregulation of the Na+fH+ exchanger. Oocytes were pre-incubated in OR-2 medium 
containing 14C-DMO for 12-14 hours with or wihtout 6-DMAP at 0, 0.063, 0.125, or 
0.25 mM. Oocytes were either left untreated (Cont) or were treated with progesterone 
(lµM). pHi was meaured 8 hours later. 6-DMAP had a small effect on the progesterone 
activation of the Na+fH+ antiporter (0.01 < p < 0.02). Results were analyzed using slope 
of the line (Zar, 1984). The data are expressed as mean± SEM, where n=3. 
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B. Cycloheximide: 
Previous studies have shown that new protein synthesis is necessary for Xenopus 
oocytes to undergo GVBD in response to progesterone stimulation (Wasserman and 
Masui, 1975). However, it is not known if protein synthesis is also required for the 
activation of the Na+/tt+ antiporter. Therefore, oocytes were pre-treated with 
cycloheximide, a specific inhibitor of protein synthesis, at lOµg/ml + 14C-DMO for 12-14 
hours and then progesterone was added. As Figure 18 shows, cycloheximide not only 
blocked progesterone-induced-GVBD, but it also significantly (p < 0.001) inhibited the 
activation of the exchanger in response to progesterone. These findings suggest that a 
protein(s) needs to be synthesized in order for the steroid to stimulate the Na+/tt+ 
anti porter. 
C. p39 mos kinase: 
1. Activation of the sodium/hydro~en antiporter in sta~e VI oocytes: 
The cycloheximide data indicated that a newly synthesized protein (s) is necessary 
for the steroid activation of the Na+/H+ antiporter and for activation of MPF. The de novo 
synthesis of p39 c-mos kinase is necessary for progesterone-induced GVBD (Sagata et al., 
1989). Therefore, I investigated the possible involvement of c-mos kinase in regulating 
the Na+JH+ antiporter. In order to do this study, I microinjected a Maltose Binding 
Protein-mos fusion protein (MBP-mos, a gift from Dr. Cooper) into full grown stage VI 
oocytes . The Xenopus mos gene was fused in frame to the malE gene of Escherichia coli, 
which codes for the maltose-binding protein (MBP). A maltose affinity column was used 
to purify the protein in one step (Yew et al., 1992). The oocytes were pre-treated with 
14C-DMO for 2 hours, then 40ngs of MBP-mos protein were microinjected into each 
oocyte. Another group of oocytes was pre-treated with 14C-DMO for 2 hours, then 
47 









Figure 18. Protein synthesis was required for the steroid activation of the exchanger and 
GVBD. Oocytes were pre-incubated in OR-2 medium containing 14C-DMO for 12-14 
hours with or without cyclohexirnide (10 µg/ml). Oocytes were either left untreated (Cont) 
or were treated with progesterone (lµM). The pHi was determined 8 hours later. 
Cyclohexirnide, a protein synthesis inhibitor, significantly blocked progesterone activation 
of the Na+/H+ antiporter (p < 0.001). The numbers in brackets refer to the fraction of 
oocytes that underwent GVBD. The data are expressed as mean± SEM, where n=3. 
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progesterone (lµM) was added. pHi and GVBD were monitored every 2 hours up to 8 
hours after microinjection of the kinase and addition of progesterone. Figure 19 shows 
that a ~0.3 pHi unit increase is seen within 2 hours following the injection of MBP-mos, 
while the same increase in pHi is Na+/H+ antiporter rapidly within 2 hours, it still took 7.5 
hours for GVBD to be seen in seen 6 hours after treatment with progesterone (Figure 20). 
This result shows that c-mos kinase is able to activate the exchanger much faster than 
progesterone can. 
Another observation made in this experiment is that even though c-mos activated the 
50% of the injected oocytes (GVBD5o) (Fig. 19). The timing of GVBD50 in progesterone-
treated oocytes was 8.5 hours (Fig. 20). These results show that c-mos kinase accelerated 
the upregulation of the Na+fH+ antiporter by 4 hours but only accelerated GVBD by 1 hour 
compared to progesterone-stimulated oocytes. Injection of MBP-mos inactive kinase had 
no effect on pHi (data not shown) and served as a negative control. 
These observations suggest that p39 c-mos kinase could be directly involved in the 
regulation of the Na+fH+ antiporter in oocytes. Therefore, this protein should be able to 
activate the Na+fH+ antiporter not only in full-grown stage VI oocytes but also in smaller 
growing oocytes that do have the Na+fH+ antiporter but do not respond to progesterone. 
2. Activation of the sodium/hydrogen antiporter in stage IV oocytes: 
Stage IV (950 µM in diameter) oocytes have a Na+fH+ antiporter, but it is not 
coupled to the progesterone pathway. Previous studies have shown that growing stage IV 
oocytes only show a small insignificant increase in pHi when treated with progesterone 
(Wasserman et al., 1986). These smaller oocytes do not synthesize c-mos or undergo 
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Figure 19. Microinjected MBP-mos kinase could rapidly activate the Na+JH+ antiporter in 
recipient oocytes. Oocytes were pre-incubated in OR-2 medium containing 14C-DMO for 
2 hours. Then, the oocytes were microinjected with MBP-mos fusion peptide at 
40ngs/oocyte. Oocyte pHi and GVBD were monitored every 2 hours. GVBD50 for 
MBP-mos injected oocytes was 7 .5 hours. Data points without error bars represent data 
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Figure 20. pHi and GVBD kinetics for progesterone-treated oocytes. Oocytes were 
pre-incubated in OR-2 medium containing 14C-DMO for 2 hours. Oocytes were treated 
with progesterone (lµM). pHi and GVBD were monitored every 2 hours. GVBD50 for 
progesterone treated oocytes was 8.5 hours. Data points without error bars represent data 
that were identical for all experiments. The data are expressed as mean± SEM, where 
n=3. 
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oocytes, it should be able to cause an increase in smaller oocytes. Therefore, stage IV 
oocytes were rnicroinjected with 20ngs of MBP-mos protein, and were then incubated in 
14C-DMO for 2 hours and pHi was determined. Another group of oocytes were 
pre-treated with 14C-DMO for 2 hours, then progesterone (lµM) was added. pHi was 
determined after 18 hours. As shown in Figure 21, the injected MBP-mos significantly 
activated the Na+JH+ antiporter within 2 hours (0.005 < p < 0.025), while 18 hours of 
treatment with progesterone had little effect on the activation of the exchanger (p > 0.5). 
These stage IV oocytes did not undergo GVBD in response to MBP-mos. Therefore, p39 
c-mos kinase can rapidly activate the Na+JH+ antiporter in smaller growing oocytes in the 
absence of GVBD. 
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Figure 21. Microinjected MBP-mos kinase could rapidly activate the Na+;H+ antiporter in 
stage IV oocytes. Stage IV oocytes (900-950 µMin diameter) were pre-incubated in OR-2 
medium containing 14C-DMO for 2 hours. One group of oocytes were stimulated with 
progesterone for 18 hours and their pHi levels were measured. A second group of oocytes 
were rnicroinjected with MBP-mos peptide at 20 ngs/oocyte. The pHi of these recipient 
oocytes were measured 2 hours later. The injected MBP-mos significantly activated the 
pump within 2 hours (0.005 < p < 0.025). The numbers in brackets refer to the fraction of 




PART I: Protein Kinase C. Ca-Calmodulin Kinase. and Protein Kinase A 
Full grown stage VI Xenopus laevis oocytes undergo many physiological changes as 
well as the meiotic reductive division in response to progesterone. All these changes 
constitute oocyte meiotic maturation (Wasserman and Smith, 1978). One of these 
physiological changes is a ~0.4 unit increase in intracellular pH (pHi) of the oocyte 
cytoplasm. Previous studies have shown that this increase may be due to the stimulation 
of the Na+/If+ antiporter present in the oocyte plasma membrane (Houle and Wasserman, 
1983; Stith and Maller, 1984). 
A Na+fH+ antiporter exchanges one sodium ion for one hydrogen ion in a reversible 
manner and it does not require the hydrolysis of ATP (Grinstein and Rothstein, 1986; 
Wakabayashi et al., 1992). The Na+/H+ antiporter plays a role in the regulation of the 
intracellular pH, control of cell volume, and initiation of growth and proliferation 
(Grinstein and Rothstein, 1986). The mammalian Na+fH+ exchanger (NHE) is a protein 
of 815 amino acids. It appears that the peptide is N-glycosylated before it is expressed on 
the cell surface (Wakabayashi et al., 1992). Several studies have suggested that the 
activation of this exchanger is the result of increased affinity for cytoplasmic H+ at a 
"hydrogen modifier" site that is distinct from the part of the peptide that transports the 
sodium and hydrogen ions (Wakabayashi et al., 1992). Several investigations have 
hypothesized that phosphorylation of the antiporter itself or an ancillary protein is 
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responsible for the regulation of the Na+fH+ antiporter (Sardet et al., 1990; Bianchini et 
al., 1991; Livne and Pouyssegur, 1991; Guizourn et al., 1993). Most studies have used 
an indirect approach to test this hypothesis. In these studies, different activators and 
inhibitors of several kinases were used to see what effect, if any, they had on the activation 
of the exchanger. Recently it has been demonstrated, using a mammalian specific antibody 
to immunoprecipitate NHE-1, that the activated antiporter itself is phosphorylated by some 
unknown kinase or kinases (Sardet et al., 1990). I wanted to use this antibody to see if 
the antiporter is phosphorylated during progesterone-induced maturation. However, I was 
told that this mammalian antibody does not cross react with Xenopus NHE (Jacques 
Pouyssegur, personal communication, August 1992). Thus, I had to use an indirect 
approach to investigate which kinase may be involved in the regulation of the oocyte 
Na+fH+ antiporter. I used different inhibitors and activators of specific kinases to see if 
they had any effect on the regulation of the Na+fH+ antiporter during progesterone- induced 
oocyte maturation. More than one inhibitor of each kinase was used. One inhibitor by 
itself may have its own limitations, but consistant results with several different inhibitors 
would tend to make my conclusions stronger. 
Numerous studies have suggested that either protein kinase C, calcium-calmodulin 
kinase, or cAMP-dependent kinase is involved in the regulation of the Na+fH+ antiporter in 
different cell systems. In this study, I examined the potential role of all three kinases in the 
regulation of the Na+fH+ antiporter during progesterone-induced oocyte maturation. 
A. Protein kinace C: 
Protein Kinase C was the first kinase investigated because there are several cell 
systems that appear to regulate their Na+fH+ antiporter via PKC (Moolenar et al., 1984; 
Lowe et al., 1990; Shen and Burck, 1990; Mitsuka et al., 1991; Nanda and Grinstein, 
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1991). As mentioned in the literature review, it has been shown that 4~-TPA, an activator 
of PKC, can cause a pHi increase in Xenopus oocytes (Stith and Maller, 1987). Recently, 
Stith et al. (1992) have demonstrated that phospholipase-C (PC-PLC), which generates 
diacylglycerol that may stimulate PKC, can also cause a pHi increase in the Xenopus 
oocytes. However, my results suggest that PKC is not involved in the regulation of the 
Na+fH+ antiporter during progesterone-induced oocyte maturation. Pre-incubation of 
oocytes with different PKC inhibitors such as H-7 or staurosporine, or the microinjection 
of the pseudosubsrate peptide inhibitor of PKC, PKC (19-36), had no significant effect on 
the stimulation of the Na+fH+ antiporter in response to progesterone. The concentrations 
of the PKC inhibitors that I used have been shown to inhibit PKC activity in other cell 
systems (Kwon and Lee, 1991; Stith et al., 1992; Slotki et al., 1990). Furthermore, it has 
been shown that G-protein-induced maturation is a PKC-dependent event in Xenopus 
oocytes and can be inhibited by microinjecting the pseudosubstrate peptide inhibitor, PKC 
(19-36) (Kroll et al., 1991), at the same concentrations I used. Therefore, my results 
suggest that the Na+fH+ antiporter can be activated artificially by 4~-TPA; however, PKC 
is not the kinase regulating the Na+fH+ antiporter in progesterone-stimulated oocytes. 
Phorbol ester, 4~-TPA, is known to be a potent activator of PKC (Nishizuka, 1984). 
However, the PKC inhibitors used in this study did not inhibit the stimulation of the 
antiporter due to 4~-TP A. Identical results were obtained in a study done on rat papillae 
medullary duct cells, where 4~-TP A caused an increase in pHi in these cells, but PKC 
inhibitors did not inhibit this increase (Slotki, 1990). The reason for this lack of inhibition 
could possibly be due to the nonspecific effects of 4~-TPA at high doses (Nishizuka, 1986; 
Billah et al., 1989; Rasmussen et al., 1987), or the possibility that 4~-TPA may not be 
working via PKC in some cases (Davis et al., 1985; Hedberg et al., 1988). It has been 
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demonstrated in transverse tubules isolated from chicken skeletal muscle that 4p-TP A can 
directly activate a Mg2+-A TPase (Kang, 1991). Ahmed et al. (1990) have also indicated 
specific 4p-TPA binding to n-chimaerin, a brain protein which has no kinase activity. A 
portion of N-chimaerin possesses 71 % amino acid identity to the highly conserved TPA 
binding domain of PKC (Ahmed et al., 1990). Other proteins such as A-Raf-1 (human) 
and DAG kinase (porcine) contain a region that has 52 and 42-62% amino acid identity to 
theTPA bindingdomainofPKC(Becketal., 1987; Sakaneetal., 1990). Raf-1 is one of 
the kinases that becomes activated during progesterone-induced maturation in Xenopus 
oocytes (see below). Therefore, 4p-TPA may be working via a non-PKC pathway in 
Xenopus oocytes to activate the Na+/H+ antiporter. 
B. Calcium-calmodulin kinase: 
Since protein kinase C was eliminated as a possible kinase regulating the Na+/H+ 
antiporter in Xenopus oocytes, calcium-calmodulin kinase was investigated. During 
fertilization in sea-urchin eggs, calcium-calmodulin kinase and PKC regulate the Na+/H+ 
antiporter (Shen, 1989; Shen and Buck, 1990). My results, however, indicate that 
calmodulin kinase does not appear to play a role in the regulation of the Na+/H+ antiporter 
in Xenopus oocytes. Microinjection of calmodulin saturated with calcium had no 
significant effect on the intracellular pH of the oocyte. The two inhibitors of calmodulin, 
calmidazolium and TFP, had no inhibitory or stimulatory effect on progesterone's ability to 
stimulate the Na+/H+ antiporter. Therefore, based on my results, it seems that neither 
calcium-calmodulin nor protein kinase C play any role in the regulation of the Na+/H+ 
antiporter during progesterone-induced oocyte maturation. Therefore, a third kinase, 
cAMP-dependent kinase (protein kinase A), was investigated. 
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C. Protein kinase A: 
cAMP/PKA appear to be involved in the regulation of the Na+/H+ antiporter in a few 
cell systems (Kong et al., 1989; Weinman et al., 1990; Borgese et al., 1992; Guizoum et 
al., 1993). Elevated levels of cAMP and PKA activity are antagonistic to progesterone's 
ability to induce germinal vesicle breakdown (Maller and Krebs, 1977; Sadler and Maller, 
1981, 1987). I have tried to increase the cAMP/PKA levels within the oocyte by two 
ways: (1) increasing the synthesis of cAMP by adenylate cyclase using forskolin and (2) 
inhibiting the degradation of cAMP by phosphodiesterase using IBMX or theophylline. 
Both approaches significantly inhibited the stimulation of the antiporter via progesterone. 
In my study, I have shown that elevated levels of cAMP and PKA activity are also 
antagonistic to progesterone's ability to induce a pHi increase during Xenopus oocyte 
maturation. Kahn et al. (1985) have also shown that elevated levels of cAMP inhibit the 
Na+JH+ antiporter in rabbit brush border membrane vesicle. However, it has already been 
shown that progesterone causes a decrease in cAMP levels and hence PKA activity in 
Xenopus oocytes during meiotic maturation (Maller and Krebs, 1977; 
Schorderet-Slatkineet al., 1982; Maller, 1983). Therefore, this antagonism is removed 
during normal oocyte maturation. 
My results suggest that PKA is not involved in the activation of the Na+JH+ antiporter 
during progesterone-induced oocyte maturation; therefore, I investigated the potential role 
of other kinases that become active during progesterone-induced oocyte maturation. 
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PART II: Other Kinases Activated Durio~ Oocyte Maturation 
As described earlier, full-grown stage VI oocytes are arrested at prophase of meiosis I 
and are released in response to progesterone (reviewed by Smith, 1989). Progesterone 
activates a number of kinases that initiate MPF activation and germinal vesicle breakdown 
(GVBD) (Sagata et al., 1989). For GVBD to occur, MPF, which is stored in the form of 
pre-MPF in prophase oocytes, has to become acticated. The activation of MPF takes place 
when a newly synthesized "initiator" protein known as p39 c-mos kinase is made (Sagata 
et al., 1989). A decrease in the synthesis of cAMP, which will result in a drop in cAMP 
level and PKA activity within the oocytes, is also necessary for MPF activation and GVBD 
(Maller and Krebs, 1977; Sadler and Maller, 1981, 1987). Both events are required for 
progesterone- induced activation of MPF and GVBD. My study has demonstrated 
cAMP/PKA levels have to drop for the stimulation of the oocyte Na+fH+ antiporter in 
response to progesterone. 
A. Cycloheximide: 
It has been shown that a newly synthesized protein is necessary for GVBD to occur in 
response to progesterone (Sagata et al., 1989). Oocytes treated with cycloheximide, a 
protein synthesis inhibitor, not only blocked GVBD in the oocytes but it also blocked 
progesterone's ability to up-regulate the Na+fH+ antiporter. This result was unexpected 
since it was thought that the kinase that was involved in regulation of the Na+fH+ antiporter 
would already be present in the oocyte, and it just had to become activated. However, the 
cycloheximide data suggested that a new protein(s) has to be synthesized for progesterone 
stimulation of the Na+/H+ antiporter in Xenopus oocytes. 
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B. p34 MPF and p39 Mos kinase: 
The cycloheximide data indicated that protein synthesis is necessary for steroid-
induced GVBD and pHi increase; however, it does not indicate which protein(s) needs to 
be made. It has been shown that the synthesis of p39 c-mos is necesary for 
progesterone-induced GVBD (Sagata et al., 1989). My results suggest that c-mos may 
also be necessary for stimulation of the exchanger during progesterone-induced oocyte 
maturation. Microinjection of MBP-mos kinase into full-grown stage VI oocytes caused a 
rapid increase in intracellular pH within 2 hours. This result is similar to the rapid 
stimulation of the Na+/H+ antiporter when oocytes were microinjected with crude 
cytoplasm taken from oocytes stimulated with progesterone (Wasserman, unpublished 
data). p39 c-mos kinase not only activated the Na+JH+ but it also caused MPF activation 
and GVBD. However, p34 MPF kinase does not appear to be involved in the regulation 
of the exchanger for several reasons. 1) 6-DMAP, the reversible inhibitor of p34cdcZ, 
completely inhibited GVBD (p34-MPF) at concentrations that had little effect on 
progesterone's stimulation of the Na+JH+ antiporter. 2) Microinjection of MBP-mos 
kinase into stage VI oocytes activated the exchanger within 2 hours which is 4 to 6 hours 
before MPF-induced GVBD is seen in these oocytes. This result means that p39 c-mos 
kinase is able to rapidly activate the exchanger without accelerating the whole maturation 
process. 3) Microinjection of MBP-mos into growing stage IV oocytes caused a rapid 
stimulation of the exchanger without inducing MPF activation and GVBD. Recent studies 
have shown that c-mos mRNA induces GVBD when injected into stage VI oocytes, but 
this mRNA does not induce GVBD when injected into stage IV oocytes (Xu et al., 1992). 
My MBP-mos protein injections into stage IV oocytes confirm these results. However, 
my results indicate that MBP-mos protein injections can cause a rapid stimulation of the 
Na+JH+ antiporter without causing MPF activation and GVBD in stage IV oocytes. It 
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appears that parts of the maturation pathway are present in the stage IV oocytes, such as 
the increase in pHi, and can be activated under certain conditions while other parts of 
pathway that lead to MPF activation are not present or incomplete. 
My results suggest that c-mos kinase itself or a kinase immediately downstream of 
c-mos is responsible for the regulation of the exchanger during progesterone-induced 
oocyte maturation. Recently, c-mos kinase has been shown to rapidly activate Xenopus 
Raf-1 kinase and p45 MAP kinase kinase in vivo and in vitro (Posada and Cooper, 1992; 
Posada et al., 1993; Nebrada and Hunt, 1993). From my results it is difficult to conclude 
whether c-mos kinase itself or another kinase immediately downstream of c-mos is directly 
involved in regulation of the Na+ /H+ anti porter via phosphorylation during 
progesterone-induced oocyte maturation. 
CHAPTERV 
CONCLUSIONS 
In summary, my study suggests that neither protein kinase C nor calcium-calmodulin 
kinase are involved in the regulation of the oocyte Na+JH+ antiporter. In an attempt to 
summarize my data Figure 22 shows that 1) A newly synthesized protein(s) is necessary 
for the stimulation of the exchanger in response to progesterone, most likely the synthesis 
of c-mos protein. 2) Elevated levels of cAMP and PKA activity are antagonistic to the 
activation of the antiporter during progesterone-induced oocyte maturation. 3) The exact 
site of PKA antagonism is unknown. However, recent studies have suggested that a 
cAMP/PKA-sensitive step exists between p39 c-mos kinase synthesis and Raf-1 kinase 
activation in Xenopus oocytes (Posada et al., 1993). It has been demonstrated that PKA 
can phosphorylate Raf-1 and inactivate it (Wu et al., 1993). 4) 4~-TPA may bind to and 
activate Raf-1 kinase which in turn stimulates the Na+JH+ antiport. Therefore, I conclude 
that p39 c-mos kinase or another kinase immediately downstream of c-mos, such as Raf-1 
kinase, is most likely the kinase that is directly involved in the regulation of the Na+JH+ 
antiporter during progesterone-induced oocyte maturation. Additional experiments will 
be necessary to determine whether c-mos or Raf-1 kinase directly phosphorylates and 
activates the Na+JH+ antiporter during progesterone-induced oocyte maturation. 
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Figure 22. Proposed model for the Na+/H+ antiport regulation. 1) A newly synthesized 
protein(s) is necessary for the stimulation of the exchanger in response to progesterone, 
most likely c-mos synthesis. 2) Elevated levels of cAMP/PKA activity are antagonistic to 
the activation of the antiporter during progesterone induced oocyte maturation. 3) 4~-TP A 
may bind to and activate Raf-1 kinase which in turn stimulates the Na+fH+ antiport. 
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